Bioantibody develops and manufactures antigens, antibodies, and downstream detection reagents using proprietary technologies such as hybridoma cell screening and recombinant antibody production. Their products address the need for accurate and rapid diagnostic solutions for infectious diseases, including COVID-19 and malaria, by providing reliable self-testing kits.
Funding
$14.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Accurate and rapid diagnostic solutions are needed for the detection of infectious diseases, especially in point-of-care and self-testing scenarios. Existing diagnostic methods may lack the speed and accessibility required for timely intervention and disease management.
Solution
Bioantibody develops, manufactures, and distributes a range of rapid diagnostic test kits and reagents for infectious diseases. Utilizing technologies such as hybridoma cell screening and recombinant antibody production, Bioantibody provides reliable and easy-to-use self-testing kits. These kits employ lateral flow assays to detect specific antigens or antibodies, delivering results within minutes. The company's product line includes tests for COVID-19, influenza, malaria, and other infectious diseases, enabling individuals and healthcare professionals to quickly assess infection status.
Target Audience
The primary target audience includes individuals seeking self-testing solutions for infectious diseases, as well as healthcare providers, diagnostic laboratories, and public health organizations requiring rapid and reliable diagnostic tools.
Features
- Rapid detection of target antigens or antibodies via lateral flow immunoassay
- Self-testing format for convenient at-home use
- High sensitivity and specificity for accurate results
- Tests available for a variety of infectious diseases, including COVID-19, influenza A/B, malaria, rotavirus, and adenovirus
- Multiplex assays for simultaneous detection of multiple pathogens
- Customizable kit configurations with options for 1, 5, or 25 tests per kit
- Long shelf life and convenient storage conditions (2-30°C)